Insights Into Mineralys Therapeutics's Upcoming Earnings
Insights Into Mineralys Therapeutics's Upcoming Earnings
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.Mineralys Therapeutics (NASDAQ:MLYS) is set to give its latest quarterly earnings report on Monday, 2024-11-11. Here's what investors need to know before the announcement.
Mineralys Therapeutics（納斯達克：MLYS）定於2024年11月11日（星期一）公佈最新季度業績。投資者在公佈之前需要了解的內容如下。
Analysts estimate that Mineralys Therapeutics will report an earnings per share (EPS) of $-0.83.
分析師預計Mineralys Therapeutics將報告每股收益（EPS）爲-0.83美元。
Anticipation surrounds Mineralys Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
投資者對Mineralys Therapeutics的公告充滿期待，希望聽到超過預期的消息，並獲得下一季度的積極指引。
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
新投資者應該了解，儘管收益表現很重要，但市場反應往往受到指引的推動。
Earnings History Snapshot
收益歷史快照
Last quarter the company missed EPS by $0.13, which was followed by a 22.82% drop in the share price the next day.
上一季度，該公司的每股收益低於0.13美元，隨後股價第二天下跌了22.82%。
Here's a look at Mineralys Therapeutics's past performance and the resulting price change:
讓我們來看看Mineralys Therapeutics過去的表現和隨之而來的價格變化：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | -0.67 | -0.82 | -0.76 |
| EPS Actual | -0.83 | -0.70 | -0.61 | -0.57 |
| Price Change % | -23.0% | -5.0% | -2.0% | -7.000000000000001% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益預估值 | -0.70 | -0.67 | -0.82 | -0.76 |
| 每股收益實際值 | -0.83 | -0.70 | -0.61 | -0.57 |
| 價格變更% | -23.0% | -5.0% | -2.0% | -7.000000000000001% |
Performance of Mineralys Therapeutics Shares
Mineralys Therapeutics股票表現
Shares of Mineralys Therapeutics were trading at $14.16 as of November 07. Over the last 52-week period, shares are up 124.06%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
截至11月7日，Mineralys Therapeutics股票交易價格爲$14.16。在過去的52周內，股價上漲了124.06%。考慮到這些回報通常是積極的，長期股東可能會看好這一業績發佈。
To track all earnings releases for Mineralys Therapeutics visit their earnings calendar on our site.
要追蹤Mineralys Therapeutics所有業績，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
